Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Journal of Trauma and Emergency Surgery
Published in: European Journal of Trauma and Emergency Surgery 1/2013

01-02-2013 | Original Article

Evaluation of current treatment regimens for prepatellar and olecranon bursitis in Switzerland

Authors: S. F. Baumbach, H. Wyen, C. Perez, K.-G. Kanz, I. Uçkay

Published in: European Journal of Trauma and Emergency Surgery | Issue 1/2013

Login to get access

Abstract

Purpose

Bursitis is a common entity. However, evidence for the best treatment procedures is lacking, with management concepts varying internationally. We evaluated current treatment regimens for septic (SB) and nonseptic (NSB) prepatellar (PB) and (OB) olecranon bursitis in Switzerland and compared them to the published literature.

Methods

A voluntary 23-item online survey was distributed amongst all registered Swiss infectiologists and orthopedic surgeons in December 2011. The literature comparison was based on a systematic literature review.

Results

Overall response rate was 14 % (n = 117); 11 % (n = 92) were included in the final analysis. The overwhelming majority (91 %) of the respondents differentiated between SB and NSB, with determination predominantly based on clinical presentation (83 %), blood chemistry (75 %), and bursal aspirate (66 %). NSB was predominantly treated conservatively via immobilization (78 %) and anti-inflammatory medication (73 %). For SB, 85 % indicated surgical intervention, with 73 % prescribing concomitant antibiotics. Regarding antibiotic choice, 90 % used an aminopenicillin or its derivatives for a mean of 11 ± 5 days. The literature review revealed 66 relevant publications with an overall level of evidence of 2b, arguing for a conservative treatment approach in cases of SB or NSB.

Conclusion

Therapeutic regimens for OB/PB differed considerably within Switzerland. Surgical intervention and antibiotic treatment was the most common therapy for SB, whereas a conservative approach predominated for NSB, which contrasts with the international literature. Clearly, prospective multicenter and multidisciplinary studies are needed to identify an optimal and cost-saving approach to the treatment of these common clinical entities.
Literature
1.
Söderquist B, Hedström SA. Predisposing factors, bacteriology and antibiotic therapy in 35 cases of septic bursitis. Scand J Infect Dis. 1986;18(4):305–11.PubMedCrossRef
2.
Smith DL, McAfee JH, Lucas LM, Kumar KL, Romney DM. Septic and non-septic olecranon bursitis. Utility of the surface temperature probe in the early differentiation of septic and non-septic cases. Arch Intern Med. 1989;149(7):1581–5.PubMedCrossRef
3.
Stell IM. Septic and non-septic olecranon bursitis in the accident and emergency department—an approach to management. J Accid Emerg Med. 1996;13(5):351–3.
4.
Laupland KB, Davies HD, Group CHPTPS. Olecranon septic bursitis managed in an ambulatory setting. The Calgary Home Parenteral Therapy Program Study Group. Clin Invest Med. 2001;24(4):171–8.
5.
Martinez-Taboada VM, Cabeza R, Cacho PM, Blanco R, Rodriguez-Valverde V. Cloxacillin-based therapy in severe septic bursitis: retrospective study of 82 cases. Joint Bone Spine. 2009;76(6):665–9.PubMedCrossRef
6.
Perez C, Huttner A, Assal M, Bernard L, Lew D, Hoffmeyer P, Uckay I. Infectious olecranon and patellar bursitis: short-course adjuvant antibiotic therapy is not a risk factor for recurrence in adult hospitalized patients. J Antimicrob Chemother. 2010;65(5):1008–14.PubMedCrossRef
7.
McAfee JH, Smith DL. Olecranon and prepatellar bursitis. Diagnosis and treatment. West J Med. 1988;149(5):607–10.PubMed
8.
McCarthy P. Managing bursitis in the athlete: an overview. Phys Sportsmed. 1989;17(11):115–25.
9.
Nussbaumer P, Candrian C, Hollinger A. Endoscopic bursa shaving in acute bursitis. Swiss Surg. 2001;7(3):121–5.PubMedCrossRef
10.
Ho G, Tice AD. Comparison of non-septic and septic bursitis. Further observations on the treatment of septic bursitis. Arch Intern Med. 1979;139(11):1269–73.PubMedCrossRef
11.
García-Porrúa C, González-Gay MA, Ibañez D, García-País MJ. The clinical spectrum of severe septic bursitis in northwestern Spain: a 10 year study. J Rheumatol. 1999;26(3):663–7.PubMed
12.
Scharf HP, Rüter A. Orthopädie und Unfallchirurgie, 1 Auflage. München: Urban & Fischer bei Elsey, 2009.
13.
Müller M. Chirurgie für Studium und Praxis 2008/09: Unter Berücksichtigung des Gegenstandskataloges und der mündlichen Examina in den Ärztlichen Prüfungen, 9 Auflage. Breisach am Rhein: Medizinsche Verlags- und Informationsdienste 2007.
14.
Damert H-G, Altmann S, Schneider W. Weichteildefekte nach komplizierter Bursitis olecrani. Therapieoptionen zur Defektdeckung am Ellenbogen. Der Chirurg 2009;80(5):448, 50–4.
15.
Henne-Bruns D, Dürig M, Kremer B, Baumann R, Gay B, Baum K (2007) Duale Reihe: Chirurgie, 3 Auflage. Stuttgart: Thieme.
16.
PEG. Empfehlungen zur kalkulierten parenteralen Initialtherapie bakterieller Erkrankungen bei Erwachsenen. Chemother J. 2010;19:179–255.
17.
Ho G, Tice AD, Kaplan SR. Septic bursitis in the prepatellar and olecranon bursae: an analysis of 25 cases. Ann Intern Med. 1978;89(1):21–7.PubMed
18.
Smith DL, McAfee JH, Lucas LM, Kumar KL, Romney DM. Treatment of nonseptic olecranon bursitis. A controlled, blinded prospective trial. Arch Intern Med. 1989;149(11):2527–30.PubMedCrossRef
19.
Shell D, Perkins R, Cosgarea A. Septic olecranon bursitis: recognition and treatment. J Am Board Fam Pract. 1995;8(3):217–20.PubMed
20.
McFarland EG, Mamanee P, Queale WS, Cosgarea AJ. Olecranon and prepatellar bursitis: treating acute, chronic, and inflamed. Phys Sportsmed. 2000;28(3):40–52.PubMed
21.
22.
23.
Weinstein PS, Canoso JJ, Wohlgethan JR. Long-term follow-up of corticosteroid injection for traumatic olecranon bursitis. Ann Rheum Dis. 1984;43(1):44–6.PubMedCrossRef
24.
Canoso JJ, Sheckman PR. Septic subcutaneous bursitis. Report of sixteen cases. J Rheumatol. 1979;6(1):96–102.PubMed
25.
Ho G, Su EY. Antibiotic therapy of septic bursitis. Its implication in the treatment of septic arthritis. Arthritis Rheum. 1981;24(7):905–11.PubMedCrossRef
26.
27.
Stell IM. Management of acute bursitis: outcome study of a structured approach. J R Soc Med. 1999;92(10):516–21.PubMed
28.
Zarzaur BL, Kozar RA, Fabian TC, Coimbra R. A survey of American association for the surgery of trauma member practices in the management of blunt splenic injury. J Trauma. 2011;70(5):1026–31.PubMedCrossRef
29.
Wyen H, Wutzler S, Maegele M, Lefering R, Nau C, Seidel D, Marzi I. Rotational bed therapy after blunt chest trauma: a nationwide online-survey on current concepts of care in Germany Injury 2011 (in press).
Metadata
Title
Evaluation of current treatment regimens for prepatellar and olecranon bursitis in Switzerland
Authors
S. F. Baumbach
H. Wyen
C. Perez
K.-G. Kanz
I. Uçkay
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
European Journal of Trauma and Emergency Surgery / Issue 1/2013
Print ISSN: 1863-9933
Electronic ISSN: 1863-9941
DOI
https://doi.org/10.1007/s00068-012-0236-4

Other articles of this Issue 1/2013

European Journal of Trauma and Emergency Surgery 1/2013 Go to the issue

Original Article

Prehospital care in patients with severe traumatic brain injury: does the level of prehospital care influence mortality?

Original Article

Abdominal vascular trauma in 760 severely injured patients

Original Article

Angiographic embolization in the treatment of arterial pelvic hemorrhage: evaluation of prognostic mortality-related factors

Review Article

Whole body imaging in the diagnosis of blunt trauma, ionizing radiation hazards and residual risk

Original Article

A practical therapeutic protocol for cervical tuberculosis

Original Article

A new fixation method for Hoffa fracture